Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancy, Using MHC Identical or Near Identical Donors and Sub-Myeloablative Conditioning With CAMPATH 1H (DIMSUM)

NCT00048412 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00048412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00048412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancy, Using MHC Identical or Near Identical Donors and Sub-Myeloablative Conditioning With CAMPATH 1H (DIMSUM)
Lead sponsor
Baylor College of Medicine
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2000
Completion date
November 12, 2004
Enrollment
40
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoproliferative disorders, multiple myeloma, myelodysplastic disorders, plasma cell dyscrasia